Paper27353166
In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline.
Zhang Y and 2 others. J Antibiot (Tokyo), 2016. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline. Papers, record 27353166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27353166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Enterobacteriaceae | Major topic |
| Tetracyclines | Major topic |
| beta-Lactamases | Major topic |
| Carbapenems | |
| Drug Resistance, Multiple, Bacterial | |
| Microbial Sensitivity Tests | |
| Polymerase Chain Reaction | |
| beta-Lactam Resistance |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26263298 | New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections. | Curr Opin Crit Care | 2015 | https://conductscience.org/library/papers/26263298 | PubMed |
| 2 | 19687234 | Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19687234 | PubMed |
| 3 | 22354310 | Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22354310 | PubMed |
| 4 | 25691636 | Eravacycline (TP-434) is efficacious in animal models of infection. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/25691636 | PubMed |
| 5 | 23219246 | Detection systems for carbapenemase gene identification should include the SME serine carbapenemase. | Int J Antimicrob Agents | 2013 | https://conductscience.org/library/papers/23219246 | PubMed |
| 6 | 24463280 | The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/24463280 | PubMed |
| 7 | 17005839 | SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/17005839 | PubMed |
| 8 | 16048978 | First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16048978 | PubMed |
| 9 | 26059625 | Healthcare-associated infections, infection control and the potential of new antibiotics in development in the USA. | Future Microbiol | 2015 | https://conductscience.org/library/papers/26059625 | PubMed |
| 10 | 24247134 | Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24247134 | PubMed |
| 11 | 25534744 | Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/25534744 | PubMed |
| 12 | 21474585 | Combating antimicrobial resistance: policy recommendations to save lives. | Clin Infect Dis | 2011 | https://conductscience.org/library/papers/21474585 | PubMed |
| 13 | 21398074 | Multiplex PCR for detection of acquired carbapenemase genes. | Diagn Microbiol Infect Dis | 2011 | https://conductscience.org/library/papers/21398074 | PubMed |
| 14 | 25277839 | Discovery and development of new antibacterial agents targeting Gram-negative bacteria in the era of pandrug resistance: is the future promising? | Curr Opin Pharmacol | 2014 | https://conductscience.org/library/papers/25277839 | PubMed |
| 15 | 24381080 | Notes from the Field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013. | MMWR Morb Mortal Wkly Rep | 2014 | https://conductscience.org/library/papers/24381080 | PubMed |
| 16 | 21840669 | Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in Detroit. | Diagn Microbiol Infect Dis | 2011 | https://conductscience.org/library/papers/21840669 | PubMed |
| 17 | 24602953 | Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae. | Infect Control Hosp Epidemiol | 2014 | https://conductscience.org/library/papers/24602953 | PubMed |
| 18 | 11257029 | Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11257029 | PubMed |
| 19 | 11036019 | SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/11036019 | PubMed |
| 20 | 25534728 | In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/25534728 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42827677 | Evaluation of eravacycline susceptibility testing by MIC test strip and disk diffusion against broth microdilution in carbapenem-resistant Enterobacterales. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42827677 | PubMed |
| 42192725 | Beyond β-Lactams: Defining the Role of Eravacycline in Multidrug-Resistant and Metallo-β-Lactamase-Producing Infections. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42192725 | PubMed |
| 41471170 | Resistance of Gram-Negative Bacteria to Eravacycline: A Systematic Review of Data from In Vitro Studies. | Pathogens | 2025 | https://conductscience.org/library/papers/41471170 | PubMed |
| 41301604 | Use of Aztreonam-Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41301604 | PubMed |
| 41269026 | Evaluating eravacycline's efficacy against pediatric carbapenem-resistant Klebsiella pneumoniae in China: a 6-year study. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/41269026 | PubMed |
| 40329078 | In vitro synergistic effect and mutant prevention concentration of eravacycline alone or in combination with various antibiotics against OXA-48 producing enterobacterales. | J Antibiot (Tokyo) | 2025 | https://conductscience.org/library/papers/40329078 | PubMed |
| 39624714 | In vitro activities of eravacycline against clinical bacterial isolates: a multicenter study in Guangdong, China. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39624714 | PubMed |
| 37509424 | In Vitro Activity of Eravacycline against Carbapenemase-Producing Gram-Negative Bacilli Clinical Isolates in Central Poland. | Biomedicines | 2023 | https://conductscience.org/library/papers/37509424 | PubMed |
| 36877080 | Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of Enterobacteriaceae and Enterococci. | J Clin Microbiol | 2023 | https://conductscience.org/library/papers/36877080 | PubMed |
| 36421250 | Update on the Management of Surgical Site Infections. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36421250 | PubMed |
| 36187949 | Drug development concerning metallo-β-lactamases in gram-negative bacteria. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36187949 | PubMed |
| 34854060 | Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates. | Infection | 2022 | https://conductscience.org/library/papers/34854060 | PubMed |
| 34169446 | Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions. | Eur J Clin Microbiol Infect Dis | 2021 | https://conductscience.org/library/papers/34169446 | PubMed |
| 32987821 | Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32987821 | PubMed |
| 32152509 | Critical analysis of antibacterial agents in clinical development. | Nat Rev Microbiol | 2020 | https://conductscience.org/library/papers/32152509 | PubMed |
| 32102899 | Epidemiology of β-Lactamase-Producing Pathogens. | Clin Microbiol Rev | 2020 | https://conductscience.org/library/papers/32102899 | PubMed |
| 31843999 | In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/31843999 | PubMed |
| 31388008 | The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase. | Nat Commun | 2019 | https://conductscience.org/library/papers/31388008 | PubMed |
| 31086308 | Antimicrobial resistance in nephrology. | Nat Rev Nephrol | 2019 | https://conductscience.org/library/papers/31086308 | PubMed |
| 30761114 | Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options. | Front Microbiol | 2019 | https://conductscience.org/library/papers/30761114 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27353166
GET https://conductscience.org/api/papers/v1/27353166/references?page=2